Both in Pharmaceuticals
Gyre Therapeutics vs Aclaris Therapeutics
Over the past year GYRE returned −2.4% and ACRS returned +175.0%; their daily moves had a correlation of 0.17.
GYRE −2.4% ACRS +175.0%Growth of $1, one year, split-adjusted
| Metric | GYRE | ACRS |
|---|---|---|
| Price | $7.32 | $5.28 |
| Market cap | $776.2M | $777.2M |
| Today | −2.27% | −2.76% |
| 1 month | +11.1% | −12.1% |
| 6 months | +7.0% | +51.3% |
| Year to date | +3.7% | +75.4% |
| 1 year | +2.2% | +165.3% |
| Revenue growth (YoY) | −2.1% | −8.3% |
| Gross margin | 92.4% | 86.6% |
| Net margin | −40.1% | −1320.1% |
| P/E (TTM) | — | — |
| Price / sales | 6.5× | 94.6× |
| Net cash | $74.8M | $91.6M |
| Dividend yield | — | — |
| Volatility (60d) | 46.8% | 56.9% |
| Short % of float | 10.3% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).